Sonire Therapeutics
Provides High-Intensity Focused Ultrasound treatment for cancer.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD38—57m (Dealroom.co estimates Sep 2022.)
Tokyo Japan (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
JPY530m | Series A | ||
| N/A | JPY900m | Late VC | |
| Total Funding | CAD15.0m | ||